Health Care/Hospital News & Press Release Distribution

Health Care/Hospital

APAC
Global

WellsCare signs in-store contract with b8ta for IASO

SEOUL, South Korea, Sept. 20, 2020 /PRNewswire/ -- WellsCare, a member company of theBorn2Global Centre, recently signed a store contract with b8ta, a famous American flagship store that is dedicated to innovative products. WellsCare has been an active member of the Born2Global Centre since 2019....

2020-09-20 20:00 2282

WellsCare signs in-store contract with b8ta for IASO

Preparation products of Yiling Pharma approved by FDA for launch in the US market

SHIJIAZHUANG, China, Sept. 19, 2020 /PRNewswire/ -- Yiling Pharmaceutical Co., Ltd. announced on Friday that it had received the approvals of the Abbreviated New Drug Applications (ANDA) about Lisinopril Tablets and Acyclovir Capsules, from United States Food and Drug Administration (hereinafter ...

2020-09-19 19:14 2594

LUFTQI Launched a Crowdfunding Campaign for the LUFT Duo Filter-Free Air Purifier

TAOYUAN, Sept. 18, 2020 /PRNewswire/ -- Multiple fast-moving wildfires are continuing to burn across Califronia,Oregon and Washington, threatening people and homes. For essential worker commuters, including gig workers, this also means potential respiratory problems for those forced to drive unde...

2020-09-18 20:00 4449

LUFTQI Launched a Crowdfunding Campaign for the LUFT Duo Filter-Free Air Purifier

BAVENCIO Pivotal Phase III JAVELIN Bladder 100 Results Published in The New England Journal of Medicine

Not intended for US-, Canada- and UK-based media DARMSTADT, Germany, and NEW YORK, Sept. 18, 2020 /PRNewswire/ -- Merck and Pfizer Inc. (NYSE: PFE) today announced the publication of detailed results from the Phase III JAVELIN Bladder 100 study online ahead of print inThe New England Journal of...

2020-09-18 15:00 10082

PolyU designs new dual-task exercise for stroke patients to effectively reduce the risk of falls and fall-related injuries

HONG KONG, Sept. 18, 2020 /PRNewswire/ -- Stroke is the fourth leading cause of death inHong Kong[1], hospitalising around 25,000 people each year[2]. Despite declines in stroke mortality over the past years, it remains one of the major causes of adult disability, greatly affecting the daily live...

2020-09-18 10:08 3404

Setting new standards for speed and compatibility: Medit launches new T-Series scanner models

SEOUL, South Korea, Sept. 18, 2020 /PRNewswire/ -- Medit announces the launch of three new T-Series laboratory scanner models; T710, T510, and T310. The new T-Series laboratory scanner lineup – the T710, T510, and T310 – is carefully designed...

2020-09-18 09:49 4067

Setting new standards for speed and compatibility: Medit launches new T-Series scanner models

Apis Partners leads US$15 million investment in Prenetics

* Investment will go into game-changing rapid COVID-19 test, highly accurate, results in 15-30 minutes, no lab required, low-cost. In discussions with Governments globally. * Enabling Travel Bubble: Prenetics, Cathay Pacific to launch pilot in October 2020 from HKG to LHR with The Commons Pro...

2020-09-18 08:00 5754

MorphoSys and I-Mab Announce FDA Clearance of IND Application for MOR210/TJ210 in Patients with Advanced Cancer

PLANEGG/MUNICH, Germany and SHANGHAI, China, Sept. 17, 2020 /PRNewswire/ -- MorphoSys AG (FSE: MOR; Prime Standard Segment, MDAX & TecDAX; NASDAQ: MOR) and I-Mab (Nasdaq: IMAB) today jointly announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug applic...

2020-09-18 04:05 10739

First patient in treatment in RhoVac's clinical phase IIb study in Sweden

STOCKHOLM, Sept. 17, 2020 /PRNewswire/ -- RhoVac AB ("RhoVac") announces today, onSeptember 17 2020, that the first patient in Sweden is enrolled in the company's clinical phase IIb study in prostate cancer, a study named RhoVac-002 ("BRaVac"). The first patient in Sweden is enrolled in the cli...

2020-09-17 23:51 3276

Dr. Steven Yu Joins ChemPartner as Vice President of Regulated Bioanalysis

SHANGHAI, Sept. 17, 2020 /PRNewswire/ -- Shanghai ChemPartner announced today the appointment ofSteven Yu, Ph.D. as Vice President of Regulated Bioanalysis at the company headquarters inShanghai, China. Dr. Yu has more than 15 years of experience in drug development and extensive expertise in...

2020-09-17 23:01 2196

Expanding Their Existing Strategic Collaboration, GenScript ProBio Licensed Global Rights to Develop and Commercialize a SMAB Bispecific Antibody Molecule to REMD Biotherapeutics Inc.

NANJING, China, Sept. 17, 2020 /PRNewswire/ -- On September 16th, 2020, GenScript ProBio and REMD Biotherapeutics Inc. (REMD) announced that REMD has licensed a bispecific antibody derived from the Single-domain antibody fused to Monoclonal Ab (SMAB) platform developed by GenScript ProBio. REMD i...

2020-09-17 22:00 2063

Happy Buy Reached Cooperation With Hive-Box, Testing Water In Community E-Commerce

NANPING, China, Sept. 17, 2020 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovativeChina-based nutraceutical and dietary supplements producer, announced today that C'est La Vie Interactive Technology Co., Ltd ("CLV") , a subsidiary of Happy Buy, has signe...

2020-09-17 22:00 18065

Nebulyft® Skincare Device Set to Transform the Anti-Aging Landscape

IRVINE, Calif., Sept. 17, 2020 /PRNewswire/ -- Rebeccatech LLC is proud to introduce the Nebulyft®, World's 1st MicroRF anti-aging device that's truly non-intrusive. nebulyft anti-aging device by Rebeccatech The Nebulyft® skincare device...

2020-09-17 21:19 1806

Nebulyft® Skincare Device Set to Transform the Anti-Aging Landscape

Asia-Pacific's 5G Digital Factory Revenue Primed for a Post-COVID-19 Recovery Worth US$60 Billion in 2030

SINGAPORE, Sept. 17, 2020 /PRNewswire/ -- COVID-19 initially slowed mobile phone sales in theAsia Pacific and disrupted supply chains and demand for certain 5G-related end verticals. However, it also caused an increase in broadband traffic and 5G use cases such asSouth Korea using 5G to livestrea...

2020-09-17 20:30 4050

Viva Biotech's Portfolio Company Dogma Therapeutics Reached the Acquisition Agreement with AstraZeneca on Dogma's Oral PCSK9 Inhibitor Program

CAMBRIDGE, Mass., Sept. 17, 2020 /PRNewswire/ -- Dogma Therapeutics ("Dogma"), a Viva Biotech Portfolio Company, has reached an agreement for the acquisition of its oral PCSK9 program by AstraZeneca. Dogma will receive upfront as well as downstream payments linked to global regulatory and commerc...

2020-09-17 20:25 3936

Turkish Student Received Full Scholarship to Pursue Dream at The University of Hong Kong

ISTANBUL, Sept. 17, 2020 /PRNewswire/ -- The University of Hong Kong (HKU) established the HKU Scholarship for Future Leaders in the 2019/20 academic year to support talented students from developing countries to pursue their dreams at HKU. Applications were received from students inGhana, Madaga...

2020-09-17 20:00 1965

China's Weifang, Ecuador's Guaranda ink ties and join hands in COVID-19 fight

WEIFANG, China, Sept. 17, 2020 /PRNewswire/ -- A video conference to share experiences of effective fight against the COVID-19 was held onSept. 11, when a signing ceremony of friendly and cooperative relations between Weifang City in China and Guaranda City in Ecuador also took place, according to...

2020-09-17 19:13 1369

China's Weifang, Ecuador's Guaranda ink ties and join hands in COVID-19 fight

Global Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 7, 2020

HONG KONG, Sept. 17, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company will hold its 20...

2020-09-17 19:00 17070

#KIDsforSDGs By Family Mask Academy

HONG KONG, Sept. 17, 2020 /PRNewswire/ -- Family Mask joined forces with Jumpstart Media to organize Jumpstart Kids: Young SDG Leaders (Junior Edition) Program to let the young leaders better understand the role of the United Nations (UN) and the 17 Sustainable Development Goals (SDGs). Young SDG...

2020-09-17 11:11 3402

The Farrer Park Company partners UOB on Singapore's first green loan for a healthcare facility

SINGAPORE, Sept. 17, 2020 /PRNewswire/ -- The Farrer Park Company Pte Ltd has obtained a S$120 million green loan from United Overseas Bank Limited (UOB), the first such loan for a healthcare facility inSingapore. The loan is issued under the UOB Real Estate Sustaina...

2020-09-17 10:30 3537

1 ... 623 624 625626627 628 629 ... 807